Synaffix B.V.: Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology
License agreement centered around development of a single ADC programUsage of Synaffix GlycoConnect®, HydraSpace® and toxSYN® ADC technologies to enhance efficacy, tolerability and target engagementAM ...